Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
semaglutide heart rate increase and cardiovascular outcomes in patients with obesity and prevalent failure: a prespecified analysis of the SELECT trial Exenatide: Uses, Side Effects, DDS Amount:7.5mg × 4 pens
Exenatide: Uses, Side Effects, Dosage & More - GoodRx
not publicly disclosed)
DDS
Amount:7.5mg × 4 pens
In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium
US$ 28.38
US$ 27.28
US$ 27.14
US$ 24.73
US$ 21.82
US$ 24.07
